Our Story

 

The World Orphan Drug Congress USA is back for its 12th edition, happening July 11-13, 2022. After many successful years in D.C., we have outgrown our usual venue and are excited to announce our move to the Boston Hynes Convention Center!

 

Since it’s inception in 2010, The World Orphan Drug Congress has solidified its position as the largest rare disease and orphan drug conference, globally. Over 3 days, you will have the opportunity to hear from 250+ speakers across our 13 themes of content, engage in networking opportunities and customize your experience at the congress. 

 

This conference attracts the entire rare disease ecosystem – breaking down silos and fostering collaboration to help rare disease patients. The leading orphan drug pharmaceutical and biotech companies, government and regulatory authorities, patient advocacy groups, payers, investors and solution providers rely on the congress to meet and brainstorm ways to advance orphan drug development and improve access to life-saving therapies.


Get ready for the most comprehensive program and inclusive gathering of rare disease stakeholders! In 2022, over 1,700 attendees, from 50+ countries, will gather in Boston, MA for a remarkable new chapter of The World Orphan Drug Congress USA.


We can’t wait to see you in Boston!

 

 

 

 

government and regulatory authorities, patient advocacy groups, payers, investors and solution providers

 

 

 

Advanced Therapies, clinical development, manufacturing, commercialization, cell and gene therapies, artificial intelligence, digital health solutions

 

 

Get Involved At World Orphan Drug Congress USA

 

To Sponsor Or Exhibit

 
 

Justin Franks
justin.franks@terrapinn.com
t/ +1 914 819 3506

 

 

 

To Speak

 
 

Claire Murphy
claire.murphy@terrapinn.com
t/ +1 646 619 1784

 

 

 

Marketing & Press Opportunities

 
 

Taylor Post 
taylor.post@terrapinn.com
t/ +1 646 619 1785